TFS Capital’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BC
RA
SAM
TFS Capital's ANGO Position: Q3 2017 in Review
TFS Capital sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 54,355 shares — an estimated $881K sold.
TFS Capital first reported a position in ANGO in Q2 2013 and held it in 17 quarters. The position peaked at $5.24M in Q4 2013. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.
- TFS Capital reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
- TFS Capital sold 54,355 AngioDynamics shares in Q3 2017, an estimated $881K.
- TFS Capital first reported a position in AngioDynamics in Q2 2013 and held it in 17 quarters.
- TFS Capital's AngioDynamics position peaked at $5.24M in Q4 2013.
- 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.
Based on TFS Capital's 13F filing for Q3 2017.